Education and Training
The Effects of Staggered Dosing on Interactions Between Paired Combinations of Nelfinavir, Ritonavir, and Saquinavir
The purpose of this study is to see if staggering doses of nelfinavir, ritonavir, and saquinavir has any effect on the interactions between these drugs.
Stanford is currently not accepting patients for this trial.
Intervention(s):
- drug: Ritonavir
- drug: Nelfinavir mesylate
- drug: Saquinavir
Eligibility
Inclusion Criteria
Patients must have:
- Absence of HIV-1 infection as documented by any licensed ELISA test kit within 14 days
prior to study entry.
Exclusion Criteria
Co-existing Condition:
Patients with the following symptoms and conditions are excluded:
- Any medical condition that, in the opinion of the investigator, would interfere with
the patient's ability to participate in this protocol.
Patients with the following prior conditions and symptoms are excluded:
- History of chronic illness such as hypertension, coronary artery disease, arthritis,
diabetes, or any chronic gastrointestinal conditions that might interfere with drug
absorption.
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
All
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Not Recruiting